Introduction {#s1}
============

Rheumatoid arthritis (RA) is a common autoimmune disease, accounting for more than 1% of the world's population ([@B28]). Although the exact cause of RA is still unclear, immunity disorder and chronic inflammation are generally considered as contribution to RA ([@B21]). In the later stages, other parts/organs of the RA patients may be affected, resulting in disability, declined quality of life, decreased ability to work ([@B5]), and improved health care utilization ([@B2]). In recent years, research has focused on the disease in the field of RA, leading to the discovery that autoantibodies can precede the clinical onset of the disease by many years ([@B29]).

Traditional Chinese medicine (TCM) techniques have shown therapeutic promise in treating RA ([@B8]). In TCM theory, RA is considered an impediment disease ("Bi" pattern in Mandarin) and is caused by the invasion of heat pathogens, wind, or dampness into the human body ([@B16]). According to RA patients symptoms further stratified, a pattern diagnosis can determined for a subgroup of the patients, and then will prescribe specific therapy based on these pattern classifications, the special treatment principle can improve clinical efficacy ([@B18]). Deficiency pattern (DP) as key pattern diagnosis among RA patients can lead to a specific treatment principle of "tonifying the DP" in clinical management ([@B31]). In the practice of TCM, it have been found that Tripterygium glycosides and qingluo tongbi granules are safe and effective in the treatment of RA DP ([@B40]), thus the treatment of RA DP has a good efficacy.

Autoantibodies can distinguish subgroups of the autoimmunity disease. Such as adult latent autoimmune diabetes and phenotypic type 2 diabetes can be distinguished by autoantibodies against zinc transporter 8, insulin, insulinoma antigen-2 and glutamic acid decarboxylase ([@B26]). There are two types of autoimmune hepatitis: type 1 (smooth muscle antibodies and antinuclear antibodies) and type 2 (liver cytosol antibodies and/or antibodies to liver and kidney microsomes type 1 and/or antibodies to liver and kidney microsomes type 3), which can be classified based on autoantibodies ([@B38]). Some scholars found that the positive rates of anti-U1 RNP antibodies were significantly different between the systemic lupus erythematosus DP and systemic lupus erythematosus TCM excess pattern groups ([@B4]). It was discovered that a significant difference exists between antinuclear antibodies in the kidney DP and kidney excess pattern groups ([@B11]). Autoantibodies have potential implications in TCM RA pattern classification.

The advent of protein chip technology has enabled a large-scale analysis of proteins to recognize biomarkers of RA subtypes, and identify the mechanisms underlying these subtypes ([@B13]). We applied contain panels of RA autoantigens arrays to profile autoantibodies in sera derived from RA DP patients, identified autoantibodies associated with RA DP, and further validated protein chip results by ELISA. Finally, we analyzed the possible network of the association between RA DP and autoantibodies.

Methods {#s2}
=======

Serum Samples {#s2_1}
-------------

All the samples were collected from female RA patients (patients with RA include RA DP and non-deficiency RA) in Henan Province Hospital of TCM, included 20 sera from RA DP, 40 sera from RA NDP (nondeficiency pattern), and 40 HC matched by age and gender. Of which 15 sera of RA DP, 15 sera of RA NDP, and 15 sera of HC were used for screening of protein chips, and all the samples were used for ELISA validation. RA patients were eligible to participate if they had met the American College of Rheumatology criteria for RA for at least one year, with functional classes of I, II, or III ([@B1]). Weakness in the waist, fatigue, dizziness, heavy limbs, nocturia, and numb limbs ([@B37]), inhibited stretching and bending in limbs, pain occurring or worsening during moodiness, pain occurring or worsening at night, and deformity were categorized in TCM RA DP ([@B31]). NDP means that there is no typical DP in the RA. Patients with RA DP were recorded with whole clinical manifestations according to TCM theory using a questionnaire, a tongue examination, and pulse diagnosis by 3 appointed TCM practitioners. Patients were included in the study only if the 3 practitioners reported consistent results. This study was approved by the Ethics Committee at the Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, and was conducted according to the standards of the Declaration of Helsinki. Written informed consent was obtained from the participants.

Gene Cloning, Expression, Purification, and Mass Spectrometry {#s2_2}
-------------------------------------------------------------

We expressed and purified seven proteins. Extraction of RNA from cells was carried out as per TRIzol reagent kit instructions (Invitrogen, CA; Lot No. 291946AX). Then amplification of genes was performed by RT-PCR using kit instructions (Biomake, Shanghai, China; Lot No: 20). The PCR product of the gene was sequenced by Sangon Biology (Shanghai, China). Proteins were over expressed in pET28a and then purified the recombinant protein by Ni-NTA kit (CWBIO, Beijing, China; Lot No.01376/20302). Purified recombinant proteins were confirmed by proteomics analyzer AB 4700 mass spectrometry (Applied Biosystems, Foster City, CA).

Fabrication of the Protein Chips {#s2_3}
--------------------------------

Thirty autoantibodies associated with RA were found by reading the literature, and then designed a protein matrix using these autoantibodies. Printed autoantigens included 22 purchased, 7 expressed proteins (SinoBiological, Beijing, China; Diarect AG, Freiburg, Germany; Arotec, São Paulo, Brazil), and 1 protein extract that was derived from human stratum corneum whole protein. A 12-hole rubber gasket (CapitalBio, Beijing, China; Lot No.0011016) was applied to each chip to form 12 individual chambers. All the proteins were printed in duplicate within chamber, and identical probe areas were fabricated in 12 chambers. Each chamber included positive spots (human IgG) and blank spots. The printed chips were allowed to remain at room temperature for 1 h before storage at 4°C.

Serum Assays on Protein Chips {#s2_4}
-----------------------------

Blocked 1 h with PBS containing 5% fetal calf serum (Lot No. 18040502), incubated 2 h with 40 μl of 1:50 dilutions of RA DP patients, RA NDP patients and HC sera, and washed three times with PBST. Then incubated with a 1:400 dilution of Cy3-conjugated goat anti-human IgG secondary antibody (Lot No. AA03187869) and followed by PBST washing three times. The chips were scanned using a microarray scanner (CapitalBio, Beijing, China).

ELISA {#s2_5}
-----

The candidate proteins were coated onto 96-well plates and overnight at 4°C. The CB coating solution was prepared as follows: 0.795 g of Na~2~CO~3~ and 1.465 g of NaHCO~3~ were dissolved in 500 ml of water and stored at 4° C. 200 μl of 5% fetal calf serum (Lot No. 18040502) was added to each well for blocked nonspecific binding. 100 μl human serum (1:50) was added to each well and incubated for 75 min at 37°C, then the plates were washed three times with PBST. 100 μl of horseradish peroxidase-labeled mouse anti-human IgG monoclonal antibody was added (1:10,000; Beijing Protein Innovation Co. Ltd; 130499) to each well for 45 min and then we washed the plates three times with PBST. 50 μl of tetramethylbenzidine substrate solution was added (makewoderbio, Beijng, China; Lot No.20180813). After this the plates were kept in a dark, room-temperature place for 8 min. The reaction was stopped after 50 μl H~2~SO~4~ entry and the immunoreactivity was measured by reading A450 (BioTek, Winooski, Vermont).

Statistical Analysis and Network Analysis {#s2_6}
-----------------------------------------

Chemiluminescent signals were acquired using microarray scanner, and the intensity value (signal intensity − background) was normalized using the mean of positive point signals. Each protein is in duplicate print, the average of each replicate is used as the final signal intensity for a given protein. Using a value of two times the standard deviation above mean~healthy~ as a cutoff value. SAS version 9.4 (SAS Institute Inc, \*LICENSE = SAS 000062456227) was used to perform means, standard deviation and the t-test, *P*-value (*P* \< 0.05) was taken as significant. Network analysis was conducted using the Ingenuity Pathway Analysis system (IPA, Ingenuity^®^ Systems, <http://www.ingenuity.com>).

Results {#s3}
=======

Baseline Characteristics of Study Subjects {#s3_1}
------------------------------------------

The characteristics of the enrolled subjects, including age, ESR, CRP, RF-IgG, RF-IgA, RF-IgM, complement C3, complement C4, anti-dsDNA, anti-CCP were shown in [**Table 1**](#T1){ref-type="table"}. The age of the RA DP patients was older than that of the RA NDP patients (*P* \< 0.0005). There was no significant difference in other indicators between the RA DP and RA NDP patients. Two groups used for protein chips technology or ELISA showed the above results.

###### 

Characteristics among the groups of enrolled subjects.

  Indicators/Groups        DP (protein chip)   NDP (protein chip)   DP (ELISA)          NDP (ELISA)
  ------------------------ ------------------- -------------------- ------------------- -----------------
  Number of subjects       15                  15                   20                  40
  Age (years)              59.8 ± 8.94\*       49.33 ± 9.66         62.32 ± 10.00\*\*   49.72 ± 12.36
  Duration of RA (month)   151.45 ± 144.11     120.14 ± 112.21      160.10 ± 160.80     96.72 ± 112.00
  ESR (mm/h)               45.53 ± 28.02       57.4 ± 29.35         50.05 ± 29.34       48.21 ± 29.77
  CRP (mg/L)               34.04 ± 38.61       39.31 ± 42.45        35.89 ± 37.29       28.78 ± 33.69
  RF-IgG (RU/ml)           32.8 ± 73.53        16.92 ± 20.94        28.29 ± 67.53       15.99 ± 23.63
  RF-IgA (RU/ml)           112.92 ± 109.71     132.11 ± 114.61      131.43 ± 110.52     124.39 ± 105.95
  RF-IgM (RU/ml)           230.93 ± 134.67     301.16 ± 171.55      260.02 ± 140.76     296.92 ± 134.08
  Complement C3 (g/L)      1.28 ± 0.24         1.26 ± 0.19          1.27 ± 0.22         1.24 ± 0.17
  Complement C4 (g/L)      0.28 ± 0.13         0.26 ± 0.08          0.29 ± 0.12         0.26 ± 0.07
  Anti-dsDNA (IU/ml)       3.53 ± 0.80         3.88 ± 0.69          3.34 ± 0.89         3.88 ± 0.76
  Anti-CCP (RU/ml)         65.58 ± 42.71       78.09 ± 51.55        71.91 ± 41.50       85.43 ± 46.56

ESR indicates erythrocyte sedimentation rate; CRP, C reactive protein; RF-IgG, rheumatoid factor immunoglobulin G; RF-IgA, rheumatoid factor immunoglobulin A; RF IgM, rheumatoid factor immunoglobulin M; Anti-dsDNA, anti-distrand-DNA antibody; Anti-CCP, anti-cyclic citrullinated peptide.

The comparisons of clinical indicators between DP and NDP. Unpaired t-test was applied to continuous variables analysis, and the data are expressed as the mean ± SD when appropriate (95% CI). The DP (protein chip) groups age vs NDP (protein chip) groups age \*P \< 0.05, DP (ELISA) groups age vs NDP groups age (ELISA) \*\*P \< 0.01.

Gene Cloning, Expression, and Purification of Proteins {#s3_2}
------------------------------------------------------

Seven proteins were expressed and purified for fabrication of protein chips. First, synthetic gene was cloned into pET28a ([**Figure 1A**](#f1){ref-type="fig"}). Second, coomassie brilliant blue staining of expressed proteins on SDS-PAGE, purified proteins were separated with 10% SDS-PAGE and then stained with coomassie brilliant blue. Visible proteins migrated at their expected molecular weights ([**Figure 1B**](#f1){ref-type="fig"}). Last, proteins from Ni-NTA resin were reassured by mass spectrometry, and the results show that putative proteins have a highly homologous identity (*P* \< 0.05).

![Gene cloning, expression and purification of autoantigens for protein chip preparation. **(A)** Synthetic gene was cloned into NdeI/XhoI digested pET28a. **(B)** Purified proteins were separated with 10% SDS-PAGE and then stained with coomassie brilliant blue. Lane 1: protein marker, Lane 2: JKTBP, Lane 3: Annexin-A2, Lane 4: Alpha-tropomysin, Lane 5: Glucose-6 phosphat, Lane 6: Hnrnp-A1, Lane 7: Hnrnp-A2B1, Lane 8: Keratins isoform of heterogeneous nuclear ribonucleoprotein D-like = JKTBP, heterogeneous nuclear ribonucleoprotein A2B1 = HnRNP A2B1, heterogeneous nuclear ribonucleoprotein A1 = HnRNP A1.](fphar-10-00755-g001){#f1}

Construction of RA-associated Protein Chips {#s3_3}
-------------------------------------------

In order to optimize the serum profiling assay, we tested a variety of different conditions in a pilot assay. And polymer-slide H was chosen for chips fabrication, 20-fold dilution was chosen as the most appropriate serum concentration, 400-fold dilution was chosen as the most appropriate Cy3-conjugated anti-human IgG antibody. Finally, we employed the protein chips containing 30 RA-associated autoantigens to perform serum profiling of samples collected from 15 DP, 15 NDP, and 15 HC subjects ([**Figure 2A**](#f2){ref-type="fig"}). Human IgG at a known concentration was printed at each chamber on the chips to serve as a control and landmark. Anti-vimentin antibodies and anti-heat shock protein 60 antibodies were incubated in 1 individual chambers for checkout the protein's activity ([**Figure 2B**](#f2){ref-type="fig"}). The results showed protein chips had a high correlation coefficient (0.978) between duplicate spots, which suggested that it was of high quality ([**Figure 2C**](#f2){ref-type="fig"}).

![Construction RA associated protein chip. **(A)** Human proteins were purified and printed in duplicate on poly-L-lysine coated microscope slides. **(B)** Correlation of spot intensities of all the duplicate pairs. The signal intensities of duplicate spots (Spot 1 versus its corresponding Spot 2) were plotted against each other. The resulting correlation coefficient was 0.97, indicating high reproducibility of the protein spotting. **(C)** To monitor the quality and relative quantity of the printed proteins on glass slides, the human protein chips were probed with anti-His antibody, followed by Cy3-labeled secondary antibody to visualize the signals, red boxes indicate HIS-tag group. Blue boxes indicate human IgG (the positive control), red boxes indicate HSP60 and VIM antibody. Sjogren syndrome antigen B = SSB, peptidyl arginine deiminase 4 = PADI4, double-stranded DNA = dsDNA, ribosomal protein P1 = Rib-P-P1, smithD2 = SmD2, ribosomal protein P2 = Rib-P-P2, nucleosome = Nu, nuclear ribonucleoprotein = NrnP, smith100 = Sm100, centromere protein b = Cen-B, sjogren syndrome antigen A = SSA, aldehyde dehydrogenase = ALDH, human leukocyte antigen-DR4 = HLA-DR4, isoform of heterogeneous nuclear ribonucleoprotein D-like = JKTBP, heterogeneous nuclear ribonucleoprotein A2B1 = HnRNP A2B1, heterogeneous nuclear ribonucleoprotein A1 = HnRNP A1, vascular endothelial growth factor A165 = VEGFA165, Heat shock protein 70 = HSP70, heat shock protein 60 = HSP60, myeloperoxidase = MPO, osteopontin = SPP1.](fphar-10-00755-g002){#f2}

Probing Results of the Protein Chips {#s3_4}
------------------------------------

We observed that autoantigens could be readily recognized by sera from DP and NDP groups, and the serum profiles also showed obvious individual-to-individual variation within among groups ([**Figure 3A**](#f3){ref-type="fig"}). To identify potential RA DP-associated autoantigens, we used microarray scanner to acquire the resultant signal intensities of all protein spots in each assay and identified the positives within each chip (see details under Methods). Protein chips results showed that RA have higher levels of anti-vascular endothelial growth factor (VEGF) A165 (P15692) antibodies than HC (*P* \< 0.005); anti-VEGFA165 antibodies levels of patients with RA DP were lower than patients with RA NDP (*P* \< 0.05); patients with RA DP have higher levels of anti-VEGFA165 antibodies than HC (*P* \< 0.01). There was no statistical difference between RA DP and RA NDP groups for other autoatibodies. Using a value of two times the standard deviation above mean~healthy~ as a cutoff value, an anti-IgG antibody reaction against VEGFA165 was observed in 2 out of 15 RA DP patients (13%), 6 out of 15 RA NDP patients (40%), 0 out of 15 HC patients (0%). Finally, to visualize the range of signal intensities, we conducted box-whisker plot analysis for anti-VEGFA165 antibodies across the various groups of sera ([**Figure 3B**](#f3){ref-type="fig"}).

![Probing results of the human protein chip with DP and NDP sera. **(A)** Fifteen DP, 15 NDP, and 15 HC serum samples were diluted 1:20 and individually incubated with the human protein chip, followed by the addition of the anti-human IgG antibody (Cy3-conjugated). Chips were dried and scanned to acquire the images. Representative areas of the images are illustrated. Red boxes indicate the positive candidate autoantigens, and blue boxes indicate human IgG (the positive control). **(B)** Fifteen DP, NDP, and 15 HC. The signal distributions of VEGFA165 reacting with the serum samples is displayed. The bar within the rectangle indicates the median value.](fphar-10-00755-g003){#f3}

Verification by ELISA {#s3_5}
---------------------

In order to validate the candidate autoantibodies identified using protein chips technology. ELISA of anti-VEGFA165 antibodies were carried out with 20 RA DP, 40 RA NDP, and 40 HC subject sera to verification. The results showed reactivity of RA serum IgG antibodies against were higher than HC (*P* \< 0.0001); the reactivity of RA DP serum IgG antibodies against were lower than NDP (*P* \< 0.05), and the reactivity of RA DP serum IgG antibodies against were higher than HC (*P* \< 0.05) ([**Figure 4**](#f4){ref-type="fig"}). Therefore, the anti-VEGFA165 antibodies were confirmed as being able to distinguish between RA DP and RA NDP.

![The result of protein chip was verified by enlarging the sample by ELISA. Sera derived from DP (n = 20), NDP (n = 40) and HC (n = 40) were tested for VEGFA165 autoantibody using VEGFA165.](fphar-10-00755-g004){#f4}

Discussion {#s4}
==========

TCM pattern classification analysis was carried out through data collected by four combined diagnostic methods, including WANG (inspection), WEN (falling-rising tone, auscultation, and olfaction), WEN (falling tone, inquiry), and QIE (palpation) ([@B27]). The "Cold," "Heat," "Deficiency," and "Excess" were four basic patterns in TCM ([@B14]). Pattern classification was the advantage of TCM, which can guide herbal prescriptions ([@B3]). Some TCM herbal formulae have been reported for the treatment of DP, such as WuziYanzong Pill, which protected the impaired spermatogenesis possibly by mediating mitochondrial energy metabolism in DP rats ([@B17]). Both crude and bran-processed rhizome of Atractylodes lancea have alleviated the symptoms of spleen DP in rats ([@B33]). Radix Astragali and its split components can promote water metabolism in rats with the syndrome of dampness stagnancy due to spleen deficiency by regulating the expression of AQPs ([@B39]). Xiaoyaosan intervention may effectively adjust the gut dysbacteriosis in functional dyspepsia ([@B25]). TCM has a good effect in treating DP.

In TCM practice, an experiential diagnosis approach has been frequently used in pattern classification in RA patients ([@B19]). In order to promote the traditional experiential diagnosis, the scientific evidence for pattern classification is essential, and it would be beneficial to understand essence of the pattern classification. The study suggested that statistical-based clinical data classification had a similar TCM pattern differentiation in RA patients ([@B12]). We had previous used integrating liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry platforms in conjunction with the Ingenuity Pathway Analysis software identified the biomarkers in RA patients with typical TCM cold or heat patterns ([@B9]; [@B10]). And we identified the network-based gene expression biomarkers for both cold- and heat-patterns of RA by obtained gene expression profilings of CD~4~ + T cells from cold-pattern RA patients and heat-pattern RA patients using microarray ([@B18]). In this study, we explored the autoantibody of sera in RA patients with typical TCM DP and NDP by protein chips technology, and anti-VEGFA165 antibodies which DP-associated in RA was identified.

Our previous study of the TCM DP-related genes network study found TCM DP is probably related to immune response ([@B31]). Mo, Na et al. found that the age of disease onset exhibited significant differences between DP and NDP, which is consistent with our research. The RA DP patients were older than the RA NDP, this finding is in agreement with the TCM theory that Qi, Xue, Yin, and Yang are more insufficient in older than in younger people ([@B32]). (Yin, things associated with the physical form of an object; Yang, things associated with energetic qualities; Qi, life force that animates the forms of the world; Xue, dense form of body fluids that have been acted upon and energized by Qi) ([@B30]). Anti-cyclic citrullinated peptides antibodies levels of patients with RA DP were higher than the RA NDP ([@B19]), and our experiments show that the level of anti VEGFA165 antibodies in patients with RA DP is lower than that in patients with RA NDP. We also found RA DP patients have higher levels of anti-VEGFA165 antibodies than HC, and confirmed RA have higher levels of anti-VEGFA165 antibodies than HC. Autoantibodies are associated with RA DP, and it may be used to classify TCM pattern.

VEGF is a dimeric glycoprotein, VEGFA, B, C, D and placenta growth factor consisted the VEGF family in mammals. VEGFA included five isoforms: VEGFA121, VEGFA145, VEGFA165, VEGFA189, and VEGFA206 ([@B22]), and VEGFA165 was the most abundant factor in most cells and tissues ([@B20]). VEGFA165 can promote the formation of new blood vessels and increased vascular permeability. Inflammation and angiogenesis were interdependent processes, and angiogenesis have significant effects on inflammatory mediators ([@B23]). VEGF165 has a direct pro-inflammatory effect in the pathogenesis of RA ([@B34]). Research has discovered the VEGFA165 levels in sera synovial fluid from RA patients are significantly higher than in synovial fluid from osteoarthritis patients ([@B15]; [@B34]).

Our research found there were statistically significant differences in anti-VEGFA165 antibodies between the RA and HC groups. We also found that anti-VEGFA165 antibodies levels of subjects with RA DP were lower than subjects with RA NDP. No statistical differences were found between RA DP and RA NDP groups and other autoantibodies. Through the analysis of the VEGF165-related pathway, we found three pathways related to autoimmunity, including IL-6 signaling, IL-8 signaling and clathrin-mediated endocytosis signaling, the IL-6 signaling pathway is most relevant compared to the other two pathways ([**Figure 5A**](#f5){ref-type="fig"}). VEGFA165 protein is expressed by synovial fibroblasts and synovial macrophages in the synovial tissues of RA patients. A study found that cultured synovial cells are able to secrete VEGFA165 when stimulated with IL-6 ([@B34]). The serum levels of IL-6 in RA patients were significantly higher than subjects in HC ([@B6]), and the DP was significantly lower than that in NDP ([@B24]).VEGFA165 plays a biological role by binding to its receptor subtypes, namely fms-like tyrosine kinase and neurohair protein-1 ([@B7]). VEGFA165 may recruit monocytes around endothelial cells in synovial membranes, where newly employed macrophages can produce IL-6 when stimulated by VEGFA165/fms-like tyrosine kinase-1 binding or *via* cell contact with activated endothelial cells ([@B34]). Thus, this creates a self-perpetuating cycle of inflammation. Short interfering RNA down-regulates neurohair protein-1 transcript products and induces spontaneous apoptosis of synovial cells, which is related to the decrease of Bcl-2 expression and the increase of Bax transport to mitochondria ([@B35]), which leads to synovial hyperplasia. And in the RA DP, swollen feet joints are more common than in RA NDP ([@B36]) ([**Figure 5B**](#f5){ref-type="fig"}). Some of the above findings may partly explain the statistically significant differences in VEGFA165 antibodies between the RA DP and RA NDP groups.

![Network analysis and schematic. **(A)** Three pathways related-VEGFA165 protein in RA, included IL-6 signaling, IL-8 signaling and clathrin-mediated endocytosis signling. **(B)** Schematic diagram of the role of VEGFA165 protein in RA.](fphar-10-00755-g005){#f5}

Limitations of this study include the fact that it is the limited sample size with the participants recruited. Due to the fact that RA patients with a single DP are not easy to obtain, since patients usually present with multiple-patterns, larger sample size study is needed in the future.

Conclusion {#s5}
==========

In this study, a protein chip containing RA associated autoantigens was successfully constructed. Using this chip, the anti-VEGF 165 antibody was found to be related to the TCM DP of RA, a finding further validated with the ELISA method. This study may promote the development of precise diagnosis and treatment of RA in TCM clinical, provide some clues for understanding the causes of DP of RA.
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